Correlation Between Anebulo Pharmaceuticals and Protokinetix

Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Protokinetix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Protokinetix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anebulo Pharmaceuticals and Protokinetix, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Protokinetix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Protokinetix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Protokinetix.

Diversification Opportunities for Anebulo Pharmaceuticals and Protokinetix

-0.6

Correlation Coefficient

Anebulo Pharmaceuticals  Protokinetix

Excellent diversification

The 3 months correlation between Anebulo and Protokinetix is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Protokinetix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protokinetix and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Protokinetix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protokinetix has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Protokinetix go up and down completely randomly.

Pair Corralation between Anebulo Pharmaceuticals and Protokinetix

Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to generate 0.81 times more return on investment than Protokinetix. However, Anebulo Pharmaceuticals is 1.23 times less risky than Protokinetix. It trades about 0.09 of its potential returns per unit of risk. Protokinetix is currently generating about 0.04 per unit of risk. If you would invest  125.00  in Anebulo Pharmaceuticals on December 22, 2024 and sell it today you would earn a total of  36.00  from holding Anebulo Pharmaceuticals or generate 28.8% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.39%
Values	Daily Returns

Anebulo Pharmaceuticals  vs.  Protokinetix

Anebulo Pharmaceuticals

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Anebulo Pharmaceuticals are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile technical and fundamental indicators, Anebulo Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Protokinetix

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Protokinetix are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Protokinetix showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Anebulo Pharmaceuticals and Protokinetix

The main advantage of trading using opposite Anebulo Pharmaceuticals and Protokinetix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Protokinetix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protokinetix will offset losses from the drop in Protokinetix's long position.

The idea behind Anebulo Pharmaceuticals and Protokinetix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.